Katharina Bruzelius

3PUBLICATIONS
3CO-AUTHORS
Pharmaceutical delivery technologiesMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 26, 2026
Safety and Pharmacokinetics of Olamkicept Doses up to 2400 mg in Healthy Japanese Men: Phase I, Randomized, Placebo-Controlled, and Double-Blind Trial.

|Jul 18, 2026
Safety and Pharmacokinetics of Single and Multiple Ascending Doses of Olamkicept up to 2400 mg in Healthy Men: Phase I, Randomized, Placebo-Controlled, and Double-Blind Trial.

|May 21, 2024
Safety, tolerability, and pharmacokinetics of single- and multiple-ascending doses of olamkicept: Results from randomized, placebo-controlled, first-in-human phase I trials.

Frank-Dietrich Wagner, Stefan Schreiber, Yu Bagger

Pageof 1

Frequent Collaborators

3 joint publications

Philippe Pinton

2 joint publications

Arjun Ravi

1 joint publications

Ola Sternebring